The Philadelphia Eagles are entering the 2016 NFL season with uncertainty at many positions.
Offensive tackle was not one of the positions the team had been concerned with. But that may all change following Monday's report that Lane Johnson is facing a 10-game suspension for violating the league's policy on performance-enhancing drugs.
Johnson, the former Oklahoma Sooners offensive lineman selected by the Eagles with the No. 4 overall pick in the 2013 NFL Draft, is appealing the suspension and told Fox's Jay Glazer that he took an amino acid that was approved by the league put tested positive for peptide.
Ken Sarnoff, the agent for Johnson released a statement on Monday denied that his client had been formally suspended, via Philly.com.
1. We are aware that a member of the media has started a rumor that Lane will be suspended for a PED violation.
2. Lane has not been suspended and any report to the contrary is false.
3. Nonetheless, we will not comment on my client's protected health information.
Johnson was suspended for the first four games of the 2014 season for violating the league's substance abuse policy, which is why he is facing such a severe punishment this time around.
Although the Eagles are expected to continue to incorporate element's of Chip Kelly's up-tempo offense, and the Eagles ranked No. 2 in the NFL in plays run off the outside shoulder of the right tackle (84), with an average gain of 4.55 yards per play, according to NFL.com.
If Johnson does have to miss games due to suspension, the Eagles would turn to either Dennis Kelly, who has appeared in 30 games over the course of his four-year career, or rookie Halapoulivaati Vaitai, who the team selected out of TCU with a fifth-round pick in the 2016 NFL Draft.
Johnson has started and played in all 44 games of his NFL career, aside from the four games he sat out in 2014.
Darren DeGaetano of WIP-FM in Philadelphia first reported the news.